Codexis, Inc. has recently announced a multi-year, exclusive supply agreement with KYORIN Pharmaceutical Co., Ltd. for t...
Kyowa Hakko Kirin Co., Ltd. announced the initiation of a phase 2 clinical study in Japan for tenapanor, a small mol...
Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for rare and ultr...
Chugai Pharmaceutical has announced that Roche has joined the World Federation of Hemophilia (WFH) Humanitarian Aid...
Taiho Pharmaceutical and Cullinan Oncology, LLC announced an agreement to develop TAS6417, a novel EGFR (epidermal growt...
Promega Corporation has announced FALCO biosystems of Kyoto, Japan, a core business company of FALCO HOLDINGS, working i...
Kaneka Corporation, Tokyo has entered into a strategic and investment agreement with an undisclosed US-based medical dev...
Sosei Group Corporation has announced that it has entered into a structured financing agreement with Medicxi, a venture ...
Chugai Pharmaceutical has announced that Roche has received notification that the EU Committee for Medicinal Produ...
Eisai Co., Ltd. and Purdue Pharma L.P. announced a six-month results from SUNRISE 2, a long-term Phase 3 clinical study ...
Bayer and Kyoto University have agreed on a strategic research alliance to jointly identify new drug targets for the tre...
Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mec...
apceth Biopharma GmbH, a contract manufacturing organization in the field of cell and gene therapy has announced that Hi...
Chinese healthcare solution leader Huadong Ningbo Medicine Co., Ltd. showcased its biotechnological skincare b...
Santen SA and NextPharma have announced that Santen’s Tampere manufacturing facility and related operations will b...
Fujitsu has enhanced its clinical trial-supporting Fujitsu Life Science Solution tsClinical DDworks21 series with the la...
The WHO has appointed Dr Takeshi Kasai as Regional Director for WHO’s Western Pacific Region, and re-app...
Toray Industries, Inc. and Meiji Seika Pharma Co., Ltd. have announced that the companies have signed an exclusive licen...
